These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2110070)

  • 1. Treatment of clomiphene citrate-resistant polycystic ovarian syndrome with pure follicle-stimulating hormone or human menopausal gonadotropin.
    McFaul PB; Traub AI; Thompson W
    Fertil Steril; 1990 May; 53(5):792-7. PubMed ID: 2110070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WITHDRAWN: Ovulation induction with urinary follicle stimulating hormone versus human menopausal gonadotropin for clomiphene-resistant polycystic ovary syndrome.
    Hughes E; Collins J; Vandekerckhove P
    Cochrane Database Syst Rev; 1996 Apr; (1):CD000087. PubMed ID: 17636586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovulation induction with urinary follicle stimulating hormone versus human menopausal gonadotropin for clomiphene-resistant polycystic ovary syndrome.
    Hughes E; Collins J; Vandekerckhove P
    Cochrane Database Syst Rev; 2000; 1996(2):CD000087. PubMed ID: 10796690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daily or alternate-day FSH therapy in patients with polycystic ovarian disease resistant to clomiphene citrate treatment.
    McFaul PB; Traub AI; Sheridan B; Leslie H
    Int J Fertil; 1989; 34(3):194-8. PubMed ID: 2567714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Optimal Ovulation Induction in Polycystic Ovary Syndrome Resistant to Clomiphene Citrate or Letrozole.].
    Chen Y; Zhang D
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Nov; 47(6):874-877. PubMed ID: 28598116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pure FSH for ovulation induction in patients with polycystic ovary syndrome and resistant to clomiphene citrate therapy.
    Neyro JL; Barrenetxea G; Montoya F; Rodriguez-Escudero FJ
    Hum Reprod; 1991 Feb; 6(2):218-21. PubMed ID: 1905311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian electrocautery versus human menopausal gonadotrophins and pure follicle stimulating hormone therapy in the treatment of patients with polycystic ovarian disease.
    Abdel Gadir A; Mowafi RS; Alnaser HM; Alrashid AH; Alonezi OM; Shaw RW
    Clin Endocrinol (Oxf); 1990 Nov; 33(5):585-92. PubMed ID: 2123759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polycystic ovary syndrome: low-dose follicle stimulating hormone administration is a safe stimulation regimen even in previous hyper-responsive patients.
    Dale PO; Tanbo T; Haug E; Abyholm T
    Hum Reprod; 1992 Sep; 7(8):1085-9. PubMed ID: 1400931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Native gonadotropin-releasing hormone for triggering follicular maturation in polycystic ovary syndrome patients undergoing human menopausal gonadotropin ovulation induction.
    Blumenfeld Z; Lang N; Amit A; Kahana L; Yoffe N
    Fertil Steril; 1994 Sep; 62(3):456-60. PubMed ID: 8062938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic low-dose follicle-stimulating hormone compared with clomiphene/human menopausal gonadotropin for induction of ovulation.
    Yong EL; Ng SC; Chan CL; Kumar J; Teo LS; Ratnam SS
    Gynecol Endocrinol; 1997 Feb; 11(1):35-42. PubMed ID: 9086338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of total testosterone for pregnancy during treatment in patients with clomiphene-citrate-resistant polycystic ovary syndrome: a pilot study.
    Li C; Cheng J; Wang J; Xue Y; Huang Z; Zhang S; Lv J
    Arch Gynecol Obstet; 2011 Sep; 284(3):757-64. PubMed ID: 21614496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial estradiol response predicts outcome of exogenous gonadotropins using a step-down dose regimen for induction of ovulation in polycystic ovary syndrome.
    Schoot DC; Hop WC; de Jong FH; van Dessel TJ; Fauser BC
    Fertil Steril; 1995 Dec; 64(6):1081-7. PubMed ID: 7589656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of ovulation with pulsatile subcutaneous administration of human menopausal gonadotropin in patients with polycystic ovary syndrome.
    Nakamura Y; Yamada H; Yoshida K; Manno T; Ubukata Y; Suzuki M; Yoshimura Y
    Horm Res; 1990; 33 Suppl 2():43-8. PubMed ID: 2128881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study on follicle stimulation and ovulation induction in polycystic ovary syndrome (PCOS).
    Ito T; Michioka T; Kobayashi M; Narimatsu A; Yamashita S; Matsuzaki H; Kuramoto T; Numa F; Yakabe A
    Horm Res; 1990; 33 Suppl 2():32-4. PubMed ID: 2128879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Letrozole and human menopausal gonadotropin for ovulation induction in clomiphene resistance polycystic ovary syndrome patients: A randomized controlled study.
    Shi S; Hong T; Jiang F; Zhuang Y; Chen L; Huang X
    Medicine (Baltimore); 2020 Jan; 99(4):e18383. PubMed ID: 31977842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovulation induction in polycystic ovarian disease by pure FSH (Metrodin). A comparison between chronic low-dose pulsatile administration and i.m. injections.
    Quartero HW; Dixon JE; Westwood O; Hicks B; Chapman MG
    Hum Reprod; 1989 Apr; 4(3):247-9. PubMed ID: 2497131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative, randomized study of low-dose human menopausal gonadotropin and follicle-stimulating hormone in women with polycystic ovarian syndrome.
    Sagle MA; Hamilton-Fairley D; Kiddy DS; Franks S
    Fertil Steril; 1991 Jan; 55(1):56-60. PubMed ID: 1898891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial experiences with subcutaneous pulsatile human menopausal gonadotropin administration: successful induction of ovulation in patients with polycystic ovarian disease.
    Rossmanith WG; Sterzik K; Wolf AS
    Int J Fertil; 1987; 32(6):460-6. PubMed ID: 2891635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant follicle-stimulating hormone (FSH; Puregon) is more efficient than urinary FSH (Metrodin) in women with clomiphene citrate-resistant, normogonadotropic, chronic anovulation: a prospective, multicenter, assessor-blind, randomized, clinical trial. European Puregon Collaborative Anovulation Study Group.
    Coelingh Bennink HJ; Fauser BC; Out HJ
    Fertil Steril; 1998 Jan; 69(1):19-25. PubMed ID: 9457926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized controlled trial of the efficacy of rosiglitazone and clomiphene citrate versus metformin and clomiphene citrate in women with clomiphene citrate-resistant polycystic ovary syndrome.
    Rouzi AA; Ardawi MS
    Fertil Steril; 2006 Feb; 85(2):428-35. PubMed ID: 16595222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.